Intelligence tag- supply chain insight
Due to the vaccine’s current ineffectiveness, Incepta Pharmaceuticals withdraws from Sinopharm’s proposal to produce the Covid-19 vaccine in China. Abdul Muktadir, chairman of Incepta, stated that the vaccine we intended to create was not currently working anywhere on the globe. 88.01% of Bangladeshis, or approximately 14.98 crore people, have received at least one vaccination dosage. At least 12.89 billion people have finished their vaccination schedule, 6.58 billion have received booster shots, and 438,706 have received their fourth dosage.